Relationship Between Growth Differentiation Factor-15 and Global Registry of Acute Coronary Events Score in Patients with Non-St Segment Elevation Acute Coronary Syndrome
DOI:
https://doi.org/10.56294/saludcyt20251403Keywords:
Ska , Nste -acs, Gdf-15, Grace scoreAbstract
Introduction: One of the main causes of hospitalization and death is NSTE-ACS. A GRACE risk score tool specifically designed for risk stratification of acute coronary syndrome patients is needed. The GRACE score has limitations related to the uncertainty of atherosclerotic plaque rupture and difficulty in predicting. GDF-15 is one possibility that is necessary because the results depend on an assessment of risk at a point in time. Elevated circulating levels of GDF-15 are associated with poor prognosis in many acute and chronic conditions including heart disease. Research linking GDF-15 with GRACE scores is limited and requires further study. analyze the relationship between GDF-15 and GRACE Score in NSTE-ACS patients. Methods: Analytical observational study with a cross-sectional method, 37 subjects were taken at Airlangga University Hospital in july-November 2024. GDF-15 levels were measured using the ELISA method using a Bio-rad reader. Analysis used the SPSS 25 series Spearman test. Results: subjects (n=40) were predominantly aged 60.98±8,592, 70% male, and 67.5% had a history of hypertension. The median GDF-15 level was 574.53 with a minimum level of 77 ng/L and a maximum of 2913 ng/L, the mean GRACE score was 95.65±18.307 with the highest score of 147. Statistical analysis showed a strong relationship between GDF-15 and the GRACE (contingency coefficient 0.724 with p 0.001). Conclusions: GDF-15 can be used as an alternative additional marker in GRACE score assessment.
References
1. Fox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van De Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). British Medical Journal [Internet] 2006 [Accessed: 23/04/2024]; 333(7578):1091–1094. Available in: https://doi.org/10.1136/bmj.38985.646481.55
2. Kumar D, Saghir T, Ahmed Khan K, Naseeb K, Ali G, Ali M, Bai R, Kumari R, Kumar H. Prognostic value of grace versus timi score for in-hospital outcomes after non-st-elevation acute coronary ssyndrome. Pakistan Heart Journal [Internet] 2021 [Accessed: 08/03/2024]; 54(4):361–366. Available in: https://doi.org/10.47144/phj.v54i4.2081
3. Widera C, Pencina MJ, Meisner A, Kempf T, Bethmann K, Marquardt I, Katus HA, Giannitsis E, Wollert KC. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome. European Heart Journal [Internet] 2012 [Accessed: 10/05/2024]; 33(9):1095–1104. Available in: https://doi.org/10.1093/eurheartj/ehr444
4. Ali Firdaus AA, Dyah Savitri A, Nobel Bistara D. Relationship between increased creatine kinase-mb levels and mortality of acute coronary syndrome (ACS) patients. The Indonesian Journal of Health Science [Internet] 2018 [Accessed: 11/05/2024]; 10(2):26–35. Available in: https://doi.org/10.32528/ijhs.v10i2.1854
5. Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, Karia K, Panguluri SK. Cardiovascular risks associated with gender and aging. Journal of Cardiovascular
[Internet] 2019 [Accessed: 10/05/2024]; 6(2):19. Available in: https://doi.org/10.3390/jcdd6020019
6. Elder P, Sharma G, Gulati M, Michos, ED. Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention. American Journal of Preventive Cardiology [Internet] 2020 [Accessed: 29/03/2024]; 2(6):100028. Available in: https://doi.org/10.1016/j.ajpc.2020.100028
7. Setyo Ramadhani BY, Rotty LW, Wantania F. Hematological features in coronary syndrome patients Acutes treated at blu rsup prof. Dr. Rd kandou Manado in 2010. Jurnal e-Biomedic [Internet] 2013 [Accessed: 29/03/2024]; 1(1):12–16. Available in: https://doi.org/10.35790/ebm.1.1.2013.1154
8. Goff Jr DC, Lloyd Jones DM, Bennett G, Coady S, D'Agostino, RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie, P, Stone NJ, Wilson PWF. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the american college of cardiology/american heart association task force on pracice guadlines. Journal of the American College of Cardiology [Internet] 2014 [Accessed: 29/03/2024]; 63(25):2935-2959. Available in: https://doi.org/10.1016/j.jacc.2013.11.005
9. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bulletin of the World Health Organization [Internet] 2010 [Accessed: 29/03/2024); 88(2):120–130. Available in: http://dx.doi.org/10.2471/BLT.08.057885
10. Visseren F, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford CA, Davos CH, Desormais I, Di Angelantonio E, Duran OHF, Halvorsen S, Richard Hobbs FD, Hollander M, Mullabayeva G. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice : Developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the european society of cardiology and 12 medical societies With the special contribution of the european association of preventive cardiology (EAPC) . European Heart Journal [Internet] 2021 [Accessed: 01/04/2024]; 42(34):3227-3337. Available in: https://doi.org/10.1093/eurheartj/ehab484
11. Amrullah S, Harun Rosjidi C, Bela Dhesa D, Try Wurjatmiko A, Hasrima H. Risk factors for acute myocardial infarction disease at dewi sartika general hospital, Kendari City. Scientific Journal of Health Works [Internet] 2022 [Accessed: 05/04/2024]; 02(02):21–29. Available in: https://stikesks-kendari.e-journal.id/jikk
12. Picariello C, Lazzeri C, Attanà P, Chiostri M, Gensini GF Valente S. The impact of hypertension on patients with acute coronary syndromes. International Journal of Hypertension [Internet] 2011 [Accessed: 01/04/2024]; 1–7. Available in: https://doi.org/10.4061/2011/563657
13. Mawardy A, Pangemanan JA, Utari Djafar D. Description of hypertension degree in acute coronary syndrome (ACS) patients at Prof. Dr. RD kandou general hospital, Manado, January - December 2014. e-CliniC [Internet] 2016 [Accessed: 01/04/2024]; 4(1). Available in: https://doi.org/10.35790/ecl.4.1.2016.11028
14. Kempf T, Björklund E, Olofsson S, Lindahl B, Allhoff T, Peter T, Tongers J, Wollert KC, Wallentin L. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. European Heart Journal [Internet] 2007 [Accessed: 09/04/2024]; 28(23):2858–2865. Available in: https://doi.org/10.1093/eurheartj/ehm465
15. Li M, Duan L, Cai YL, Li HY, Hao BC, Chen JQ, Liu HB. Growth differentiation factor 15 is associated with cardiovascular outcomes in patients with coronary artery disease. Cardiovascular Diabetology [Internet] 2020 [Accessed: 09/04/2024]; 19(120):2-12. Available in: https://doi.org/10.1186/s12933-020-01092-7
16. Georgiopoulos G, Kraler S, Mueller-Hennessen M, Delialis D, Mavraganis G, Sopova K, Wenzl FA, Räber L, Biener M, Stähli BE, Maneta E, Spray L, Iglesias JF, Coelho-Lima J, Tual-Chalot S, Muller O, Mach F, Frey N, Duerschmied D, Stamatelopoulos K. Modification of the GRACE risk score for risk prediction in patients with acute coronary syndromes. JAMA Cardiology [Internet] 2023 [Accessed: 11/04/2024]; 8(10):946–956. Available in: https://doi.org/10.1001/jamacardio.2023.2741
17. Yan J, Deng CJ, Wang SF, Aimaitijiang M, Wu TT, Zheng YY, Xie X, Ma YT. Predictive value of the modified GRACE scoring system for all-cause mortality in patients with acute myocardial infarction. Reviews in Cardiovascular Medicine [Internet] 2023 [Accessed: 11/04/2024]; 24(6):161. Available in: https://doi.org/10.31083/j.rcm2406161
18. Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, Olofsson S, Venge P, Larsson A, Hulthe J, Elmgren A, Wollert KC. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the prospective investigation of the vasculature in uppsala seniors (PIVUS) study. European Heart Journal [Internet] 2009 [Accessed: 11/04/2024]; 30(19):2346–2353. Available in: https://doi.org/10.1093/eurheartj/ehp261
19. Zhang S, Dai D, Wang X, Zhu H, Jin H, Zhao R, Jiang L, Lu Q, Yi F, Wan X, Cui H. Growth differentiation factor – 15 predicts the prognosis of patients with acute coronary syndrome: a meta-analysis. BMC Cardiovascular Disorders [Internet] 2016 [Accessed: 17/03/2024]; 16(82):1–7. Available in: https://doi.org/10.1186/s12872-016-0250-2
20. Sokmen E, Ucar C, Sivri S, Celik M, Guclu K. Relationship of growth differentiation factor-15 with aortic stiffness in essential hypertension. Future Science OA [Internet] 2019 [Accessed: 08/03/2024]; 5(7):1–10. Available in: https://doi.org/10.2144/fsoa-2019-0029
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Resza Rahmiyanti, Puspa Wardhani, Muhammad Robi’ul Fuadi (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
